These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19428574)
1. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution. de Moura WC; de Araujo HP; Cabello PH; Romijn PC; Leite JP J Virol Methods; 2009 Jun; 158(1-2):84-92. PubMed ID: 19428574 [TBL] [Abstract][Full Text] [Related]
2. Validation of a virus neutralization potency test in BHK-21 cells for rabies immunoglobulins in a two-center study. de Moura WC; Gallina NM; Fuches RM; Romijn PC; Leite JP J Virol Methods; 2008 Dec; 154(1-2):7-13. PubMed ID: 18851992 [TBL] [Abstract][Full Text] [Related]
3. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine]. Miceli G; Torroba JE; Diaz AM Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759 [TBL] [Abstract][Full Text] [Related]
4. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency. Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013 [TBL] [Abstract][Full Text] [Related]
5. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)]. Oei HL; Krauss H Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901 [TBL] [Abstract][Full Text] [Related]
6. Comparison studies on potency tests for rabies vaccines. Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943 [TBL] [Abstract][Full Text] [Related]
8. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity. Tint H; Rosanoff EI Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393 [TBL] [Abstract][Full Text] [Related]
9. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach. Akkermans AM; Hendriksen CF Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799 [TBL] [Abstract][Full Text] [Related]
10. Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution - Part 2. Machado NS; Moreira WC; Freitas JFS; Almeida AECC; Moura WC Biologicals; 2020 Jul; 66():30-34. PubMed ID: 32448736 [TBL] [Abstract][Full Text] [Related]
11. Production of inactivated rabies vaccine for human use on WI38 diploid cells. Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms. Nicolas AJ; Patet J; Falquet JC; Branche R; Delaiti P; Montagnon B; Peyron L; Soulebot JP Dev Biol Stand; 1978; 40():17-24. PubMed ID: 680392 [TBL] [Abstract][Full Text] [Related]
12. The rabies peripheral challenge test: more accurate determination of vaccine potency. Wunderli PS; Dreesen DW; Miller TJ; Baer GM Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854 [TBL] [Abstract][Full Text] [Related]
13. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine. Fitzgerald EA; Needy CF Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606 [TBL] [Abstract][Full Text] [Related]
14. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines. Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the usefulness of the peripheral test for determination of rabies vaccine potency]. Wysokińska T; Janaszek W; Rymkiewicz D; Słowikowska M Med Dosw Mikrobiol; 1996; 48(3-4):211-3. PubMed ID: 9182144 [TBL] [Abstract][Full Text] [Related]
16. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement. Hendriksen CF Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973 [TBL] [Abstract][Full Text] [Related]